Alliancebernstein L.P. Acquires 123,648 Shares of Bath & Body Works, Inc. $BBWI

Alliancebernstein L.P. grew its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 2.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,861,444 shares of the company’s stock after purchasing an additional 123,648 shares during the quarter. Alliancebernstein L.P. owned about 2.84% of Bath & Body Works worth $150,991,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. JPMorgan Chase & Co. boosted its holdings in Bath & Body Works by 11.5% during the second quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock worth $212,120,000 after buying an additional 733,000 shares during the last quarter. Cooper Creek Partners Management LLC increased its stake in shares of Bath & Body Works by 42.7% in the 2nd quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock valued at $162,081,000 after acquiring an additional 1,619,276 shares during the last quarter. American Century Companies Inc. raised its position in shares of Bath & Body Works by 2,204.1% in the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after acquiring an additional 4,949,796 shares during the period. AQR Capital Management LLC raised its position in shares of Bath & Body Works by 17.1% in the 3rd quarter. AQR Capital Management LLC now owns 4,921,968 shares of the company’s stock valued at $126,790,000 after acquiring an additional 718,642 shares during the period. Finally, GMT Capital Corp boosted its stake in Bath & Body Works by 8.8% during the 2nd quarter. GMT Capital Corp now owns 4,067,000 shares of the company’s stock worth $121,847,000 after acquiring an additional 329,300 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on BBWI shares. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a report on Tuesday, March 3rd. Citigroup lowered shares of Bath & Body Works from a “buy” rating to a “neutral” rating and increased their target price for the stock from $21.00 to $25.00 in a report on Tuesday, February 17th. Morgan Stanley reissued an “equal weight” rating and issued a $18.00 price target (down from $43.00) on shares of Bath & Body Works in a report on Friday, November 21st. Guggenheim initiated coverage on shares of Bath & Body Works in a research report on Tuesday, December 9th. They issued a “neutral” rating for the company. Finally, UBS Group lifted their target price on Bath & Body Works from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Monday, February 23rd. Three research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $24.00.

Bath & Body Works Stock Up 4.8%

Shares of BBWI stock opened at $20.44 on Tuesday. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $34.66. The firm has a fifty day moving average of $22.37 and a 200-day moving average of $22.98. The company has a market capitalization of $4.18 billion, a price-to-earnings ratio of 6.49, a P/E/G ratio of 1.95 and a beta of 1.48.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, March 4th. The company reported $2.05 EPS for the quarter, beating the consensus estimate of $1.77 by $0.28. The business had revenue of $2.72 billion for the quarter, compared to analysts’ expectations of $2.59 billion. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The firm’s revenue was down 2.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.09 EPS. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Friday, February 20th were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 3.9%. The ex-dividend date of this dividend was Friday, February 20th. Bath & Body Works’s dividend payout ratio is currently 25.40%.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.